| Literature DB >> 25936295 |
S De Carolis1, A Botta1, S Salvi1, E di Pasquo2, G Del Sordo1, C Garufi1, A Lanzone1, M P De Carolis3.
Abstract
The best therapy regimen for refractory obstetrical antiphospholipid syndrome remains to be determined. Additional treatments with steroids, plasma exchanges and immunoglobulins failed to show any beneficial effect. We present a case of a woman who had a better pregnancy outcome after the administration of hydroxychloroquine (HCQ) as additional treatment. Furthermore, we highlighted that HCQ was able to dramatically reduce the antiphospholipid antibodies levels.Entities:
Mesh：
Substances：
Year: 2015 PMID： 25936295 DOI： 10.1016/j.autrev.2015.04.010
Source DB: PubMed Journal: Autoimmun Rev ISSN： 1568-9972 Impact factor: 9.754